Form 4: ANI Pharmaceuticals SVP, Generics, Ori Gutwerg, Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, reports the disposal of shares to cover tax obligations related to vesting restricted stock.
Summary
- On March 7, 2025, Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, disposed of 3,314 shares of common stock at a price of $60.62.
- This transaction was to cover tax obligations related to the vesting of 6,476 shares of restricted stock.
- Following the transaction, Gutwerg directly owns 90,778 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral as it reports a routine transaction related to tax obligations. It's a standard procedure and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders trade their company's stock. This provides transparency to the market.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of stock disposal transaction |
| 03/14/2025 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.